CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 52 enrolled
Drug / intervention
Watermelondietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04015544
NCT04015544N/ACompleted
CompareCT.gov

Expression of Systemic Markers of Atherosclerosis in Free-living, Overweight, Postmenopausal Women Following Daily Watermelon Consumption for Six Weeks: A Randomized Controlled Trial

Appalachian State University·interventional·Posted Jul 11, 2019·Updated Jul 11, 2019

In Brief

A clinical study evaluating Watermelon for Postmenopausal and Overweight and Obesity. Completed, enrolled 52 participants across 1 site.

Detailed Summary

The primary purpose of this study is to determine the effectiveness of six weeks of watermelon puree supplementation, compared to control (no treatment), on blood antioxidant capacity, inflammation markers in the blood, biomarkers of metabolism in the blood, and cardiovascular disease markers in the blood, and biomarkers in the blood related to watermelon ingestion in overweight post-menopausal women. The secondary purpose is to compare body composition and body mass between the watermelon supplement group and the control group.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostmenopausal, Overweight and Obesity
CountriesUnited States
CollaboratorsNational Watermelon Promotion Board; https://www.watermelon.org

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJul 11, 2019
Enrollment StartApr 1, 2014
Primary CompletionJul 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 7.0 years ago

Interventions

Watermelondietary

Pureed whole (100%) watermelon